Dr. Aristotle Voineskos is the Vice President of Research and Director of the Campbell Family Mental Health Research Institute at CAMH. He leads a team of nearly 200 scientists and over 600 research staff committed to making discoveries to improve the quality of life for people served by CAMH, and beyond, through brain science, clinical research, health services research, and policy and population health research. Dr. Voineskos has an outstanding track-record as a clinician, a scientist, and a leader, driving change to improve care for people with mental illness.
Dr. Voineskos earned his MD and PhD at the University of Toronto, and completed a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. Dr. Voineskos founded the Kimel Family Translational Imaging-Genetics Laboratory at CAMH. He was also the inaugural Director of the Slaight Family Centre for Youth in Transition at CAMH, and served as the Chief of the Schizophrenia Division. He has won numerous awards for research and academic excellence nationally and internationally. His scientific impact ranges from brain mapping in mental illness to scaling system-level initiatives in mental health care.
Dr. Voineskos is known for his international research leadership in psychosis and schizophrenia, serving on the editorial board of Schizophrenia Bulletin, and as the co-Chair of the Schizophrenia International Research Society 2021 meeting. He has published over 200 papers many of which are in the leading journals of psychiatry, neurology, medicine, and neuroscience. In addition, he is known for his leadership on large-scale international multi-centre research initiatives across disciplines funded by the Canadian Institutes of Health Research and National Institute of Mental Health in the United States. A dedicated teacher and mentor, he is a Professor in the Department of Psychiatry at the University of Toronto, holds a Canada Research Chair, and serves on the Scientific Council of the Brain and Behavior Research Foundation (BBRF).Areas of Research
Dr. Voineskos holds a special interest in leading and planning multi-centre research. He currently holds operating funding as Principal Investigator from the NIMH, CIHR, CFI, and University of Toronto.
In the Kimel Lab, Dr. Voineskos’s work with scientists and trainees uses multi-modal neuroimaging across the lifespan in mental illnesses such as schizophrenia, bipolar disorder, autism, and Alzheimer's disease to understand changes in brain circuitry in relation to behaviour. Advanced neuroimaging techniques are also applied in treatment studies to understand effects of interventions on brain structure and function, and predict response. Novel work is now aimed toward understanding subgroup and individual brain profiles in relation to behaviour and treatment planning.
For more information, view the Kimel Family Lab page.
In the Slaight Centre, Dr. Voineskos works with a number of other scientists and team-members to identify biomarkers of early signs of psychosis, improving service delivery for youth with early psychosis, and working with youth, family, policy makers, researchers, and clinicians to effect health system change for those dealing with psychosis or schizophrenia.
For more information visit the Slaight Family Centre for Youth in Transition page.
View Dr. Voineskos' publications on PubMed.